Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  20, 467 - 472 (2002)
doi:10.1038/nbt0502-467

Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo

Thi My Anh Neildez-Nguyen1, Henri Wajcman2, Michael C. Marden3, Morad Bensidhoum4, Vincent Moncollin1, Marie-Catherine Giarratana1, Ladan Kobari1, Dominique Thierry4 & Luc Douay1, 5

1  Institut National de la Santé et de la Recherche Médicale (INSERM) U417, Hôpital Saint-Antoine, Paris, France.

2  INSERM U468, Hôpital Henri Mondor, 94010 Créteil, France.

3  INSERM U473, Hôpital de Bicêtre, 94276 Le Kremlin-Bicêtre, France.

4  Institut de Protection et de Sûreté Nucléaire, DPHD, SARAM, IPSN, 92265 Fontenay-aux-Roses, France.

5  Service d'Hématologie Biologique, Hôpital Armand Trousseau, Paris, France.

Correspondence should be addressed to Luc Douay luc.douay@trs.ap-hop-paris.fr
New sources of red blood cells (RBCs) would improve the transfusion capacity of blood centers. Our objective was to generate cells for transfusion by inducing a massive proliferation of hematopoietic stem and progenitor cells, followed by terminal erythroid differentiation. We describe here a procedure for amplifying hematopoietic stem cells (HSCs) from human cord blood (CB) by the sequential application of specific combinations of growth factors in a serum-free culture medium. The procedure allowed the ex vivo expansion of CD34+ progenitor and stem cells into a pure erythroid precursor population. When injected into nonobese diabetic, severe combined immunodeficient (NOD/SCID) mice, the erythroid cells were capable of proliferation and terminal differentiation into mature enucleated RBCs. The approach may eventually be useful in clinical transfusion applications.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Globin Synthesis
Nature Encyclopaedia of Life Sciences

REVIEWS
The anemia of vitamin A deficiency: epidemiology and pathogenesis
European Journal of Clinical Nutrition Reviews (03 Apr 2002)

RESEARCH
Functional characterization of human CD34+ cells that express low or high levels of the membrane antigen CD111 (nectin 1)
Leukemia Original Article (01 Jun 2003)
Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood
Bone Marrow Transplantation Original Article (01 Nov 2002)
Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
Bone Marrow Transplantation Original Article (01 Feb 2000)
 See all 7 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy